BPD STAR Pilot Trial

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

3 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

This study will test whether supplemental oxygen therapy, a common post-discharge treatment for BPD, improves outcomes. Enrolled infants, between the ages of 34-44 weeks Post Menstrual Age, with moderate or severe BPD, will be randomly assigned to higher or lower oxygen saturation target ranges. The study intervention will begin in the hospital and will continue at home until 6 months Corrected Age.

Who Do I Contact?

If you are interested in participating in the study or want to learn more please contact our study team at fregenen [at] chop.edu or 267-425-1998.

Eligibility & Criteria

IRB #:
17-014522
Official Title:
The Bronchopulmonary Dysplasia Saturation TARgeting (BPD STAR) Pilot Trial
Study Phase:
Pilot
Eligible Age Range:
0 - 6 Months
Gender:
All
Study Categories: